Videos

Featured

HFA 23: Trientine-HCL for Treatment of HFrEF

James L Januzzi, Harriette Van Spall,

Watch time: 4m 3s

Daniel Lenihan, , , et al

Watch time: 1h
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure

Stephen J Greene,

Watch time: 5m 11s
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt,

Watch time: 3m 50s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal,

Watch time: 8m 47s
HFA 23: MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring

Jasper J Brugts,

Watch time: 2m 45s

Jasper J Brugts, Ahmad Masri , Marianna Fontana, et al

Watch time: 1h 42m 27s (14 videos)

Daniel Lenihan, ,

Watch time: 1h
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s

Trending

Daniel Lenihan, ,

Watch time: 1h

Daniel Lenihan, , , et al

Watch time: 1h

Jasper J Brugts, Ahmad Masri , Marianna Fontana, et al

Watch time: 1h 42m 27s (14 videos)

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 1h 36m 49s (11 videos)
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)
EuroPCR 23: 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag

Mirvat Alasnag,

Watch time: 4m 28s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s
HFA 23: MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring

Jasper J Brugts,

Watch time: 2m 45s
AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s

Events

Filter by

HFA 23: Trientine-HCL for Treatment of HFrEF

James L Januzzi, Harriette Van Spall,

Watch time: 4m 3s
HFA 23: IRONMAN: Anemia, Iron Deficiency and Quality of Life

Paul Kalra,

Watch time: 5m 25s
HFA 23: Diagnosis in Heart Failure in Women

John GF Cleland,

Watch time: 8m 22s
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure

Stephen J Greene,

Watch time: 5m 11s
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers

John GF Cleland,

Watch time: 8m 44s
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt,

Watch time: 3m 50s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal,

Watch time: 8m 47s
HFA 23: MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring

Jasper J Brugts,

Watch time: 2m 45s
HFA 23: DAPA-HF and DELIVER: KCCQ in Pts with Varying Ejection Fraction

Ankeet Bhatt,

Watch time: 4m 45s

Latest

Filter by

HFA 23: Trientine-HCL for Treatment of HFrEF

James L Januzzi, Harriette Van Spall,

Watch time: 4m 3s

Daniel Lenihan, , , et al

Watch time: 1h
HFA 23: IRONMAN: Anemia, Iron Deficiency and Quality of Life

Paul Kalra,

Watch time: 5m 25s
HFA 23: Diagnosis in Heart Failure in Women

John GF Cleland,

Watch time: 8m 22s
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure

Stephen J Greene,

Watch time: 5m 11s
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers

John GF Cleland,

Watch time: 8m 44s
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt,

Watch time: 3m 50s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s